These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2567038)

  • 21. 5-HT(3) receptor antagonists and anxiety; a preclinical and clinical review.
    Olivier B; van Wijngaarden I; Soudijn W
    Eur Neuropsychopharmacol; 2000 Mar; 10(2):77-95. PubMed ID: 10706989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.
    Sánchez-Lopez A; Centurión D; Vázquez E; Arulmani U; Saxena PR; Villalón CM
    Br J Pharmacol; 2003 Oct; 140(4):725-35. PubMed ID: 14504136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats.
    Kasahara K; Hashimoto S; Hattori T; Kawasaki K; Tsujita R; Nakazono O; Takao K; Kawakubo H; Nagatani T
    J Pharmacol Sci; 2015 Jan; 127(1):109-16. PubMed ID: 25704026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists.
    Prosser RA; Dean RR; Edgar DM; Heller HC; Miller JD
    J Biol Rhythms; 1993; 8(1):1-16. PubMed ID: 8490207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin-1A anxiolytics: an overview.
    Feighner JP; Boyer WF
    Psychopathology; 1989; 22 Suppl 1():21-6. PubMed ID: 2567039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limbic mechanisms of anxiolytics acting on 5-HT receptors.
    Płaźnik A; Kostowski W; Stefański R
    Pol J Pharmacol; 1994; 46(5):473-7. PubMed ID: 7894537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonergic involvement in haloperidol-induced catalepsy.
    Neal-Beliveau BS; Joyce JN; Lucki I
    J Pharmacol Exp Ther; 1993 Apr; 265(1):207-17. PubMed ID: 8386235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models.
    Gupta D; Radhakrishnan M; Thangaraj D; Kurhe Y
    Eur J Pharmacol; 2014 Jul; 735():59-67. PubMed ID: 24747753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
    Schoeffter P; Hoyer D
    J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent developments in 5HT-related pharmacology of animal models of anxiety.
    Gardner CR
    Pharmacol Biochem Behav; 1986 May; 24(5):1479-85. PubMed ID: 2873594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonergic neurons in the median raphe nucleus regulate inhibitory avoidance but not escape behavior in the rat elevated T-maze test of anxiety.
    Dos Santos L; de Andrade TG; Zangrossi H
    Psychopharmacology (Berl); 2005 Jun; 179(4):733-41. PubMed ID: 15619105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of serotonin in depression and anxiety.
    Baldwin D; Rudge S
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():41-5. PubMed ID: 7622823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-HT-1A receptor responsiveness following subchronic administration of buspirone.
    Khan A; Haleem DJ
    Pak J Pharm Sci; 2006 Oct; 19(4):333-7. PubMed ID: 17105715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin excitation of facial motoneurons: receptor subtype characterization.
    Rasmussen K; Aghajanian GK
    Synapse; 1990; 5(4):324-32. PubMed ID: 2360199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.
    Koek W; Patoiseau JF; Assié MB; Cosi C; Kleven MS; Dupont-Passelaigue E; Carilla-Durand E; Palmier C; Valentin JP; John G; Pauwels PJ; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1998 Oct; 287(1):266-83. PubMed ID: 9765347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
    Briones-Aranda A; López-Rubalcava C; Picazo O
    Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.